Greenwich LifeSciences annual total assets
2019
2020
2021
2022
2023
2024
2025
Greenwich LifeSciences Total Assets Growth & History (GLSI)
Greenwich LifeSciences's total assets was $6.2M for fiscal 2025.
View full Greenwich LifeSciences company overviewGreenwich LifeSciences annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $6.2M | $2.1M | +50.91% |
| 2024 | 2024-12-31 | $4.1M | −$2.9M | −41.47% |
| 2023 | 2023-12-31 | $7.0M | −$6.5M | −48.10% |
| 2022 | 2022-12-31 | $13.5M | −$13.7M | −50.48% |
| 2021 | 2021-12-31 | $27.2M | −$1.5M | −5.09% |
| 2020 | 2020-12-31 | $28.7M | $28.6M | +107419.79% |
| 2019 | 2019-12-31 | $26,671 | — | — |
Greenwich LifeSciences quarterly total assets
Q4.19
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $8.9M | $5.8M | +184.03% |
| Q1 2026 | 2026-03-31 | $10.5M | $7.8M | +281.90% |
| Q4 2025 | 2025-12-31 | $6.2M | $2.1M | +50.91% |
| Q3 2025 | 2025-09-30 | $3.8M | −$2.0M | −34.64% |
| Q2 2025 | 2025-06-30 | $3.1M | −$4.1M | −56.77% |
| Q1 2025 | 2025-03-31 | $2.8M | −$2.8M | −50.08% |
| Q4 2024 | 2024-12-31 | $4.1M | −$2.9M | −41.47% |
| Q3 2024 | 2024-09-30 | $5.8M | −$3.3M | −36.34% |
| Q2 2024 | 2024-06-30 | $7.2M | −$3.7M | −34.00% |
| Q1 2024 | 2024-03-31 | $5.5M | −$6.4M | −53.77% |
| Q4 2023 | 2023-12-31 | $7.0M | −$6.5M | −48.10% |
| Q3 2023 | 2023-09-30 | $9.1M | −$6.5M | −41.53% |
| Q2 2023 | 2023-06-30 | $11.0M | −$6.2M | −36.32% |
| Q1 2023 | 2023-03-31 | $11.9M | −$7.8M | −39.66% |
| Q4 2022 | 2022-12-31 | $13.5M | −$13.7M | −50.48% |
| Q3 2022 | 2022-09-30 | $15.6M | −$13.3M | −45.89% |
| Q2 2022 | 2022-06-30 | $17.2M | −$12.6M | −42.32% |
| Q1 2022 | 2022-03-31 | $19.8M | −$10.7M | −35.06% |
| Q4 2021 | 2021-12-31 | $27.2M | −$1.5M | −5.09% |
| Q3 2021 | 2021-09-30 | $28.9M | $22.6M | +360.94% |
| Q2 2021 | 2021-06-30 | $29.8M | — | — |
| Q1 2021 | 2021-03-31 | $30.4M | — | — |
| Q4 2020 | 2020-12-31 | $28.7M | $28.6M | +107419.79% |
| Q3 2020 | 2020-09-30 | $6.3M | — | — |
| Q4 2019 | 2019-12-31 | $26,671 | — | — |
Greenwich LifeSciences total assets trends
Over the last five fiscal years, Greenwich LifeSciences's total assets decreased from $28.7M to $6.2M, a change of −$22.5M. The latest reported quarter, Q2 2026, shows $8.9M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Greenwich LifeSciences source filings ↗